NHS takes makers of generic drugs to court for price fixing
نویسندگان
چکیده
منابع مشابه
Government orders inquiry as price of generic drugs soars.
1151 BMJ VOLUME 319 30 OCTOBER 1999 www.bmj.com An inquiry into the generic drugs market has been ordered by the UK government amid evidence that some non-branded drugs now cost seven times the prices charged a year ago. In the past year, the antibiotic amoxicillin, for example, has risen from 47p ($0.75) to £1.69 for a 250 mg pack of tablets. A 100 mg pack of thyroxine has gone up in price fro...
متن کاملLattice gauge-fixing for generic covariant gauges
We propose a method which allows the generalization of the Landau lattice gauge-fixing procedure to generic covariant gauges. We report preliminary numerical results showing how the procedure works for SU(2) and SU(3). We also report numerical results showing that the contribution of finite lattice-spacing effects and/or spurious copies are relevant in the lattice gauge-fixing procedure.
متن کاملEstimating Price Variability in Agriculture: Implications for Decision-Makers
Using a stochastic version of the POLYSYS modeling framework, an examination of projected variability in agricultural prices, supply, demand, stocks, and incomes is conducted. Random yield and export shocks are introduced in each of 100 iterations of a ten-year simulation and planted acreage, production, total use, ending stock, stock-to-use, season average price, and net return results are pre...
متن کاملBioequivalence of generic drugs.
Generic drugs are bioequivalent to the original brand; this is a prerequisite for marketing approval. It is theoretically possible that one generic drug may overestimate the pharmacokinetic (PK) parameters of the original and another generic may underestimate these PK parameters; in consequence, these 2 generics may not be bioequivalent between themselves. The result could be loss of efficacy o...
متن کاملGeneric Scrip Share and the Price of Brand-name Drugs: The Role of Consumer Choice
Pharmaceutical expenditures have grown rapidly in recent decades, and now total nearly 10% of health care costs. Generic drug utilization has risen substantially alongside, from 19% of scrips in 1984 to 47% in 2001, thus tempering expenditure growth through significant direct dollar savings. However, generic drugs may lead to indirect savings as well if their use reduces the average price of th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2004
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.329.7456.12-a